Pharma News

NIH study reveals Our brains may ripple before remembering

  • Posted on: 16 March 2019
  • By: Shalini.Sharma

A sound, a smell, a word can all flood our minds with memories of past experiences. In a study of epilepsy patients, researchers at the National Institutes of Health found that split seconds before we recall these events tiny electrical waves, called ripples, may flow through key parts of our brains that help store our memories, setting the stage for successful retrieval.

Health Ministry takes stock of the public health measures for controlling West Nile Virus

  • Posted on: 15 March 2019
  • By: Shalini.Sharma

A section of the media has reported that a seven year old boy from Malappuram District of Kerala is suffering from a West Nile Virus (WNV), a mosquito-borne disease, mostly reported in the continental United States. Union Minister of Health and Family Welfare is closely monitoring the situation and has spoken to the State Health Minister of Kerala in this regard. He has directed for all support to be extended to Kerala in its prevention and management.

Scientists find new approach that shows promise for treating cystic fibrosis

  • Posted on: 15 March 2019
  • By: Shalini.Sharma

Researchers say a widely-used antifungal drug may hold promise for treating people with cystic fibrosis, a life-threatening genetic disorder that causes serious damage to the lungs. In studies using human cells and animals models, the researchers found that the medication, called amphotericin, helps lung cells function in a way that could make it easier for patients to fight chronic bacterial lung infections that are a hallmark of the disease.

NIH study reveals differences in brain activity in children with anhedonia

  • Posted on: 15 March 2019
  • By: Shalini.Sharma

Researchers have identified changes in brain connectivity and brain activity during rest and reward anticipation in children with anhedonia, a condition where people lose interest and pleasure in activities they used to enjoy. The study, by scientists at the National Institute of Mental Health (NIMH), part of the National Institutes of Health, sheds light on brain function associated with anhedonia and helps differentiate anhedonia from other related aspects of psychopathology.

FDA approves a new generic valsartan

  • Posted on: 13 March 2019
  • By: Shalini.Sharma

U.S. Food and Drug Administration approved a new generic of Diovan (valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart failure. The FDA prioritized the review of this drug application to help relieve the recent shortage of this critical medicine as a result of multiple recalls of generic valsartan products from several manufacturers due to the finding that certain lots of valsartan and other ARB medicines contain nitrosamine impurities.

Lower costs associated with late-preterm steroid therapy, NIH-funded analysis finds

  • Posted on: 13 March 2019
  • By: Shalini.Sharma

An analysis of a previous study has found more evidence to support giving the steroid betamethasone to pregnant women at risk of late-preterm delivery (between 34 and 36 weeks of gestation), according to a network funded by the National Institutes of Health. Hospital stays for infants whose mothers received the drug cost less on average, compared to stays for infants whose mothers did not take the drug. The study appears in JAMA Pediatrics.

NIH adds eight Lasker Clinical Research Scholars

  • Posted on: 13 March 2019
  • By: Shalini.Sharma

The National Institutes of Health has selected eight scientists as Lasker Clinical Research Scholars, part of a joint initiative with the Albert and Mary Lasker Foundation, to foster the next generation of great clinical scientists. This highly competitive program provides talented, early stage researchers the opportunity to carry out independent clinical and translational research for five to seven years at NIH.

Pages